Desteklenen Projeler
11
-
2015 - Devam Ediyor Phase 1 2a Study To Evaluate the Safety Pharmacokinetics Pharmacodynamics and Preliminary Efficacy of the Combination of Ibrutinib with Nivolumab in Subjects with Hematologic Malignancies
-
2015 - Devam Ediyor Open Label Phase 2 Study to Evaluate Efficacy and Safety of Daratumumab in Relapsed or Refractory Mantle Cell Lymphoma Diffuse Large B Cell Lymphoma and Follicular Lymphoma J J
-
2015 - Devam Ediyor A Phase three randomized observed blind plasebo control multicentre clinical trial to assess to prohylactic efficiency safety and immunogeneticy of GSK biological herpes zoster GE AS01b Candidate Vaccine 115523 Zoster 002
-
2016 - 2024 A Phase II/III, Randomised, Multicentre Study of MOR00208 with Bendamustine versus Rituximab with Bendamustine in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma (R-R DLBCL) Who Are Not Eligible for High-Dose Chemotherapy (HDC) and Autologous Stem-Cell Transplantation (ASCT)
-
2017 - 2019 Kök Hücre Ürününde ki CD34+ Hüre Alt Grupları ve Engrafman İle İlişkisi
-
2017 - 2019 Kök Hücre Ürününde ki CD34 Hüre Alt Grupları ve Engrafman İle İlişkisi
-
2012 - 2018 GSK Zoster-002 (115523)
-
2015 - 2017 Allojeneik Kök Hücre Nakli (AKHN) Hastalarında Nakil Öncesi ve Sonrası BV Virüs
-
2010 - 2015 Alisertib MLN8237 or Investigator s Choice in Patients With Relapsed Refractory Peripheral T Cell Lymphoma
-
2009 - 2015 Ülkemizde Hematolojik Kanserlerin Yükü Coğrafi Dağılımı Demografik Karekteristliği İmmünhistokimyasal Özellikleri ve Klinik Deneyimi
-
2009 - 2014 Efficacy and Safety Study of Budesonide to Treat Oral Chronic Graft vs Host Disease cGvHD
